سعر ميكومك 250مجم 10 اقراص 2022

Mycomic 250 mg, 10 tablets (Future Pharmaceutical Industries (FPI) > Tabuk Pharmaceutical Manufacturing Company): oral terbinafine tablets for dermatophyte infections. Clinical evidence from a US terbinafine hydrochloride 250 mg tablet SPL (same strength/route).

• Onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium); confirm diagnosis with appropriate nail specimens before treatment (US terbinafine tablets label).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Common adverse reactions include headache, diarrhea, rash, dyspepsia, liver enzyme abnormalities, pruritus, taste disturbance, nausea, abdominal pain and flatulence (US terbinafine tablets label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Chronic or active liver disease; history of allergic reaction to oral terbinafine (risk of anaphylaxis) (US terbinafine tablets label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hepatotoxicity including liver failure (sometimes requiring transplant or fatal) has been reported — discontinue if liver injury develops. Taste/smell disturbance, depressive symptoms, severe skin/hypersensitivity reactions (SJS/TEN/DRESS), thrombotic microangiopathy and lupus-like effects are labelled risks; see full US label.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Available human data are insufficient to evaluate drug-associated risk of major birth defects or miscarriage; animal studies at up to 12–23× MRHD did not show malformations. Use only if potential benefit justifies potential risk (US terbinafine tablets label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.